How healthcare companies build enterprise value

Get all six high-resolution diagrams from the Enterprise Value Creation System™ — ready for your board, your leadership team, or your next investor conversation.

Download the Free Framework Guide →

Built for the conversations that matter most.

Most strategic frameworks describe what to do. The Enterprise Value Creation System™ shows what actually happens — where value is created inside a healthcare company, where it gets lost, and what the companies that earn premium outcomes do differently.

Each framework is a working tool: something you can put in front of your leadership team, your board, or a potential investor to create shared clarity on where the business stands and what needs to change.

The guide includes all six frameworks in a single high-resolution PDF — clean, board-ready, and shareable.

What's inside the guide

The Growth vs. Enterprise Value Gap

Growth and enterprise value don't move together automatically. Over time, a gap opens between what a business is producing and what it's actually worth. This framework shows how that gap forms, why it widens silently, and what closes it. It's the conceptual foundation of the entire system, and the most common blind spot for mid-market CEOs preparing for a transaction.

Commercial Clarity

Buyers form a valuation opinion long before diligence begins. This framework maps how commercial clarity — or the lack of it — shapes buyer perception at every stage of a deal. It shows what creates confidence in a company's story and where fragmentation quietly erodes it. Useful for leadership alignment before any external process starts.

The Commercial System Architecture

Most early-stage GTM models stop working at scale. This framework defines what a repeatable, transferable commercial system looks like in healthtech — the structural elements that make growth legible to buyers, not just visible on a dashboard. Built for companies that have grown fast and need to grow cleanly.

Exit Readiness

Exit readiness isn't a checklist you complete in the 90 days before a process. It's a state of the business built over time. This framework defines the five dimensions buyers evaluate when assessing whether a company is acquisition-ready, and where most mid-market companies have gaps they don't see until pressure hits.

The Buyer Evaluation Model

This is how buyers actually evaluate healthcare companies. Before they look at your financials, they're already forming a view of your business based on clarity, consistency, and proof of performance. This framework maps those evaluation signals — what builds buyer confidence and what quietly destroys it — so leadership teams can see the business the way a buyer sees it.

Enterprise Value Drivers

Not all revenue is valued equally. This framework breaks down the specific drivers that determine how a healthcare company is valued at exit, and which ones carry the most weight with strategic acquirers and PE buyers. It gives leadership teams a clear lens for prioritizing growth decisions against their actual impact on enterprise value.

Download our EVCS frameworks guide for healthcare CEOs who want to maximize enterprise value before an upcoming transaction.

The Enterprise Value Creation System™ and all six frameworks are excerpted from Winning in Healthcare: Lessons from Legends by Dr. Roxie Mooney. But you don't need to have read the book to use them. For bulk licensing or speaking inquiries, contact growth@legacy-dna.com.

Built for leaders, not analysts

These frameworks are designed to be used at the leadership level — in board presentations, in conversations with investors, and in the internal alignment work that determines whether a company is ready for what comes next.
They're especially useful if you are:
A CEO preparing for a transaction in the next 12–36 months who wants your leadership team aligned on what buyers actually evaluate
A CMO or growth leader who needs a clear, shared language for connecting GTM decisions to enterprise value
A PE operating partner who wants a consistent framework for assessing and improving commercial maturity across a portfolio
Dashboard mockup

About Legacy DNA

Legacy DNA works with healthtech and pharmacy companies with $10M–$250M in revenue, preparing for scale, investment, or exit.

Want to apply the frameworks to your company?

The frameworks show the pattern. A Strategic Fit Call is where we apply it to your specific situation — your stage, your gaps, and what's most likely to move your valuation before the next critical conversation.

Book your Strategic Fit Call

A 30-minute conversation for PE-backed and mid-market healthtech and pharmacy leaders exploring Legacy DNA's growth and exit readiness programs.

No pitch. No pressure. Just an honest read.

Book my call